首页> 外文期刊>Journal of Ayurveda and Integrative Medicine >An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation
【24h】

An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation

机译:一项开放性,前瞻性临床研究,用于评估TLPL / AY / 01/2008在功能性便秘治疗中的疗效和安全性

获取原文
       

摘要

Functional constipation is one of the most common gastrointestinal symptoms across the globe. Its high prevalence rate, economic burden, and adverse implications on the quality of life make constipation a major public health issue. Though various treatment options are available for the management of constipation, evidence for their efficacy and safety are limited. An open-label, prospective, interventional, and exploratory clinical trial was carried out to evaluate the efficacy and safety of “TLPL/AY/01/2008” in 34 patients suffering from functional constipation. “TLPL/AY/01/2008” is an Ayurvedic proprietary polyherbal formulation in powder form, containing Isabgol husk, Senna extract, and Triphala extract. Administration of “TLPL/AY/01/2008” for 14 days showed a significant increase in mean weekly bowel movements from 10.19 ± 05.64 to 18.29 ± 05.72 (P<0.05). The mean average time spent on toilet for bowel evacuation reduced significantly from 11.02 ± 05.43 minutes (baseline value) to 08.70 ± 04.72 minutes on day 14 (P<0.05). Mean stool form score assessed on Bristol stool form scale was improved from 02.97 ± 00.48 (baseline value) to 04.61 ± 00.84 (P<0.05) on day 14. A significant improvement (P<0.05) was also noted in straining during defecation, sensation of incomplete evacuation, sensation of anorectal blockage, and other associated symptoms of functional constipation. The significant improvement in most of the above symptoms was endured for a post-treatment observatory period of one week. All the study patients showed an excellent tolerability to the study drug. These findings suggest that “TLPL/AY/01/2008” is an effective, safe, and non-habit-forming herbal laxative formulation for the management of constipation. Comparative clinical studies with larger sample size would be able to confirm the above findings.Keywords: Clinical trial, functional constipation, Isabgol, laxative, Senna, Triphala
机译:功能性便秘是全球最常见的胃肠道症状之一。便秘的高患病率,经济负担以及对生活质量的不利影响使便秘成为主要的公共卫生问题。尽管有多种治疗便秘的方法可供选择,但其有效性和安全性的证据有限。进行了一项开放性,前瞻性,干预和探索性临床试验,以评估“ TLPL / AY / 01/2008”在34例功能性便秘患者中的疗效和安全性。 “ TLPL / AY / 01/2008”是粉末形式的阿育吠陀专有多草药配方,包含伊莎博果壳,番泻叶提取物和三叶草提取物。施用“ TLPL / AY / 01/2008” 14天后,平均每周排便次数从10.19±05.64显着增加到18.29±05.72(P <0.05)。第14天,上厕所排便的平均时间从11.02±05.43分钟(基线值)显着减少到08.70±04.72分钟(P <0.05)。在第14天,以布里斯托尔粪便量表评估的平均粪便形式得分从02.97±00.48(基线值)提高到04.61±00.84(P <0.05)。在排便,感觉过程中的紧张状态中也发现了显着改善(P <0.05)疏散不全,肛门直肠阻塞的感觉以及其他相关的功能性便秘症状。在治疗后的一周观察期内,上述症状大部分都得到了明显改善。所有研究患者均显示出对研究药物的极好的耐受性。这些发现表明,“ TLPL / AY / 01/2008”是一种有效,安全且无习惯的用于治疗便秘的中草药泻药制剂。较大样本量的比较临床研究将能够证实上述发现。关键词:临床试验,功能性便秘,伊莎糖,缓泻剂,番泻叶,Triphala

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号